Le Lézard
Classified in: Health
Subjects: PER, PET, ANW

Elanco Announces Addition of New North America and Global Strategy Senior Executive


GREENFIELD, Ind., Jan. 11, 2018 /PRNewswire/ -- Today, Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY), named Sarena Lin as senior vice president, North America Operations and Global Strategy, joining Elanco's Leadership Team and reporting to Elanco president, Jeffrey Simmons.

Sarena Lin to join Elanco Animal Health as the New North America and Global Strategy Senior Executive

Lin will manage the entirety of the company's U.S. and Canadian food and companion animal businesses. She will also oversee global strategy for the top-tier animal health company, applying her extensive knowledge in corporate development to grow and strengthen Elanco's business.

"I am incredibly pleased Sarena is joining Elanco, bringing her deep expertise growing and leading global multi-billion dollar organizations - spanning consumer package goods, distribution and agriculture - to Elanco to drive our business forward and provide value to our customers," said Jeff Simmons, president, Elanco Animal Health. "I am confident her unique capabilities will enhance our strong North American team and enrich our global growth strategy."

Lin, who has a proven track record leading and growing large, multi-national organizations, most recently oversaw Cargill's global animal feed and nutrition business. She also currently serves on the Board of Directors for animal health and dental distributor, Patterson Companies, and before her time as president at Cargill, she was the global head of strategy and business development there. She was a principal at McKinsey & Company and began her career at consumer package goods giant Proctor & Gamble (P&G). She holds three university degrees with a Bachelor's in Computer Science from Harvard University, a Master's in International Relations from Yale University and a MBA from Yale School of Management.

"Elanco's vision and trajectory within this growing industry are an exciting combination," said Lin. "I am looking forward to bringing my passion for animal health and analysis-based strategy to such an industry thought leader. I feel this is a perfect partnership at an exciting time for Elanco."

Lin will start her new position on January 22 at Elanco's Greenfield, Indiana-based headquarters.

About Elanco
Elanco provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 70 countries around the world. We value innovation, both in scientific research and daily operations, and strive to cultivate a collaborative work environment for more than 6,500 employees worldwide. Together with our customers, we are committed to raising awareness about global food security, and celebrating and supporting the human-animal bond. Founded in 1954, Elanco is a division of Eli Lilly and Company. Our worldwide headquarters and research facilities are located in Greenfield, Indiana. Visit us at Elanco.com and EnoughMovement.com.

 

Elanco 2-D logo

SOURCE Elanco Animal Health


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: